Biocon Shares Rise 5% After USFDA Clears Bengaluru Facility with Favorable Rating
Shares of Biocon rose by 5 percent on November 11 after the US Food and Drug Administration (FDA) granted its Bengaluru biologics unit a “Voluntary Action Indicated” (VAI) status. This designation is generally positive, indicating minor issues found during the inspection but no need for regulatory or enforcement action, allowing Biocon to continue operations smoothly. […]
Biocon Shares Rise 5% After USFDA Clears Bengaluru Facility with Favorable Rating Read More »